HAL vs TRDA
Halliburton Company (HAL) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the HAL and TRDA stock pages for the full models.
Not investment advice.